SLE ANTIBODIES TO NEURONS AND LYMPHOCYTES: PATHOBIOLOGY
SLE ANTIBODIES TO NEURONS AND LYMPHOCYTES: PATHOBIOLOGY
批准号:
3152006
负责人:
HARRY G BLUESTEIN
金额:
$22.62万
依托单位国家:
美国
项目类别:
财政年份:
1981
资助国家:
美国
项目状态:
已结题
起止时间:
1981-07-01 至 1987-03-31
关键词:
T lymphocyte antibody formation antigen antibody reaction autoradiography blood brain barrier blood tests cell mediated cytotoxicity cell population study cerebrospinal fluid gel electrophoresis human subject immunoregulation lymphocyte membrane activity nervous system disorder neurons orphan disease /drug radiotracer scintillation spectrometry surface antigens systemic lupus erythematosus tissue /cell culture
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Central nervous system dysfunction is a common occurrence in systemic lupus
erythematosus, and it is one of the serious life-threatening manifestations
of the disease. Immune complex-mediated vasculitis, the mechanism
responsible for tissue damage in most organ systems, is rarely found in the
brain of patients with CNS disease. A major research effort in this
laboratory has been the investigation of the role of antibodies reactive
with neuronal cells from human brain in the pathogenesis of lupus
neuropsychiatric manifestations. Our studies have demonstrated that most
lupus patients have circulating antibodies reactive with human neurons, and
many of those antibodies are cross-reactive with antigens on human
lymphocytes. A pathogenetic role for those antibodies is suggested by the
close association of antineuronal antibody within the central nervous
system and active CNS lupus. In this application we are proposing more
detailed analysis of the disease-producing potential of the neuron and
lymphocyte reactive antibodies. Our aims are to understand how these
antibodies get into the nervous system and to define the antigens with
which they react. We will determine if the antibodies are produced locally
within the central nervous system or if they enter from the serum through a
leak in the blood-brain barrier. We will investigate their reactivity with
the neurotransmitter receptors that regulate brain function, and we will
utilize the neuron and lymphocyte reactive antibodies to physically
characterize the antigens shared by those two cell types and analyze their
distribution on lymphocyte subpopulations as a probe into the potential
link between altered immune regulation and nervous system dysfunction that
characterize SLE.
期刊论文(7)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Neuropsychologic deficits and antineuronal antibodies in pediatric systemic lupus erythematosus.
儿童系统性红斑狼疮的神经心理缺陷和抗神经元抗体。
DOI:
--
发表时间:
1990
期刊:
Clinical and experimental rheumatology
影响因子:
3.7
作者:
[Papero,PH, Bluestein,HG, White,P, Lipnick,RN]
通讯作者:
Lipnick,RN
DOI:
10.1084/jem.164.2.393
发表时间:
1986-08-01
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
[Pischel KD, Bluestein HG, Woods VL Jr]
通讯作者:
Woods VL Jr
Antineuronal antibodies in systemic lupus erythematosus.
系统性红斑狼疮中的抗神经元抗体。
DOI:
10.1002/art.1780250711
发表时间:
1982
期刊:
Arthritis and rheumatism
影响因子:
--
作者:
[Bluestein,HG, WoodsJr,VL]
通讯作者:
WoodsJr,VL
DOI:
10.4049/jimmunol.138.1.226
发表时间:
1987-01
期刊:
Journal of immunology
影响因子:
4.4
作者:
[K. Pischel;M. Hemler;C. Huang;H. Bluestein;V. Woods]
通讯作者:
K. Pischel;M. Hemler;C. Huang;H. Bluestein;V. Woods
Antigenic polymorphism of human very late activation protein-2 (platelet glycoprotein Ia-IIa). Platelet alloantigen Hca.
人极晚激活蛋白-2(血小板糖蛋白 Ia-IIa)的抗原多态性。
DOI:
10.1172/jci113984
发表时间:
1989
期刊:
The Journal of clinical investigation
影响因子:
--
作者:
[WoodsJr,VL, Pischel,KD, Avery,ED, Bluestein,HG]
通讯作者:
Bluestein,HG
共 6 条
CORE--SAMPLE/TISSUE ACQUISITION
-
批准号:6100562
-
项目类别:
-
资助金额:$0.0万
-
财政年份:1998
-
负责人:HARRY G BLUESTEIN
-
依托单位:
CORE--SAMPLE/TISSUE ACQUISITION
-
批准号:6235772
-
项目类别:
-
资助金额:$16.46万
-
财政年份:1997
-
负责人:HARRY G BLUESTEIN
-
依托单位:
MULTIPURPOSE ARTHRITIS & MUSCULOSKELETAL DISEASE CENTER
-
批准号:2006220
-
项目类别:
-
资助金额:$92.34万
-
财政年份:1991
-
负责人:HARRY G BLUESTEIN
-
依托单位:
MULTIPURPOSE ARTHRITIS & MUSCULOSKELETAL DISEASE CENTER
-
批准号:2882268
-
项目类别:
-
资助金额:$91.38万
-
财政年份:1991
-
负责人:HARRY G BLUESTEIN
-
依托单位:
MULTIPURPOSE ARTHRITIS & MUSCULOSKELETAL DISEASE CENTER
-
批准号:2667806
-
项目类别:
-
资助金额:$89.83万
-
财政年份:1991
-
负责人:HARRY G BLUESTEIN
-
依托单位:
MULTIPURPOSE ARTHRITIS & MUSCULOSKELETAL DISEASE CENTER
-
批准号:6164019
-
项目类别:
-
资助金额:$78.72万
-
财政年份:1991
-
负责人:HARRY G BLUESTEIN
-
依托单位:
SLE ANTIBODIES TO NEURONS & LYMPHOCYTES--PATHOBIOLOGY
-
批准号:3155741
-
项目类别:
-
资助金额:$16.23万
-
财政年份:1981
-
负责人:HARRY G BLUESTEIN
-
依托单位:
SLE ANTIBODIES TO NEURONS & LYMPHOCYTES: PATHOBIOLOGY
-
批准号:3155738
-
项目类别:
-
资助金额:$13.93万
-
财政年份:1981
-
负责人:HARRY G BLUESTEIN
-
依托单位:
SLE ANTIBODIES TO NEURONS & LYMPHOCYTES: PATHOBIOLOGY
-
批准号:3155736
-
项目类别:
-
资助金额:$13.78万
-
财政年份:1981
-
负责人:HARRY G BLUESTEIN
-
依托单位:
ANTIBODIES TO NEURONS AND LYMPHOCYTES--PATHOLOGY
-
批准号:3155739
-
项目类别:
-
资助金额:$14.42万
-
财政年份:1981
-
负责人:HARRY G BLUESTEIN
-
依托单位:
SLE ANTIBODIES TO NEURONS & LYMPHOCYTES--PATHOBIOLOGY
-
批准号:3155737
-
项目类别:
-
资助金额:$16.18万
-
财政年份:1981
-
负责人:HARRY G BLUESTEIN
-
依托单位:
SLE ANTIBODIES TO NEURONS & LYMPHOCYTES: PATHOBIOLOGY
-
批准号:3155740
-
项目类别:
-
资助金额:$15.65万
-
财政年份:1981
-
负责人:HARRY G BLUESTEIN
-
依托单位:
CELLULAR CONTROL OF EB VIRUS IN RHEUMATOID ARTHRITIS
-
批准号:3155347
-
项目类别:
-
资助金额:$21.42万
-
财政年份:1979
-
负责人:HARRY G BLUESTEIN
-
依托单位:
CELLULAR CONTROL OF EB VIRUS IN RHEUMATOID ARTHRITIS
-
批准号:3155344
-
项目类别:
-
资助金额:$18.64万
-
财政年份:1979
-
负责人:HARRY G BLUESTEIN
-
依托单位:
CELLULAR CONTROL OF EB VIRUS IN RHEUMATOID ARTHRITIS
-
批准号:3155345
-
项目类别:
-
资助金额:$18.61万
-
财政年份:1979
-
负责人:HARRY G BLUESTEIN
-
依托单位:
CELLULAR CONTROL OF EB VIRUS IN RHEUMATOID ARTHRITIS
-
批准号:3151542
-
项目类别:
-
资助金额:$14.8万
-
财政年份:1979
-
负责人:HARRY G BLUESTEIN
-
依托单位:
CELLULAR CONTROL OF EB VIRUS IN RHEUMATOID ARTHRITIS
-
批准号:3155343
-
项目类别:
-
资助金额:$17.81万
-
财政年份:1979
-
负责人:HARRY G BLUESTEIN
-
依托单位:
CELLULAR CONTROL OF EB VIRUS IN RHEUMATOID ARTHRITIS
-
批准号:3155346
-
项目类别:
-
资助金额:$19.74万
-
财政年份:1979
-
负责人:HARRY G BLUESTEIN
-
依托单位:
RHEUMATIC DISEASES
-
批准号:2077648
-
项目类别:
-
资助金额:$7.47万
-
财政年份:1975
-
负责人:HARRY G BLUESTEIN
-
依托单位:
CORE--SAMPLE/TISSUE ACQUISITION
-
批准号:3728170
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:HARRY G BLUESTEIN
-
依托单位:
海外基金